http://bjbms.org/ojs/index.php/bjbms/issue/feed Bosnian Journal of Basic Medical Sciences 2020-11-02T00:00:00+01:00 Faruk Skenderi faruk.skenderi@bjbms.org Open Journal Systems <p>The BJBMS (Bosnian Journal of Basic Medical Sciences) is а premier venue for discoveries in basic and clinical biomedical science. The BJBMS was founded in 1998 and is published by the Association of Basic Medical Sciences, a nonprofit honor organization of physician-scientists.</p> <p>Broad readership and scope. The BJBMS reaches readers across a wide range of medical disciplines and sectors. The journal publishes basic and translational/clinical research submissions and reviews in all biomedical specialties, including Genetics and Molecular biology, Immunology, Microbiology, Pathology, Biochemistry, Pharmacology, Anatomy, Biomaterials, new and emerging research and diagnostic methods, new and emerging medical entities, and others.</p> http://bjbms.org/ojs/index.php/bjbms/article/view/4614 Immunohistochemical study of dental pulp cells with 3D collagen type I gel in demineralized dentin tubules in vivo 2020-09-18T13:03:38+02:00 Sultan Zeb Khan zebsultan681@gmail.com Sana Mirza resperioprof@gmail.com Samina Karim professional3792@gmail.com Takashi Inoue inoue@tdc.ac.jp Mohammed S. Bin-Shuwaish shuwaishmo@gmail.com Laila Al Deeb laldeebacademic@gmail.com Khold Al Ahdal akholdacademic@gmail.com Rana S. Al-Hamdan alhamdanrs@gmail.com Ahmed M. Maawadh maawadhaa@gmail.com Fahim Vohra fahimvohra@yahoo.com Tariq Abduljabbar academicksa1@gmail.com <p>Dental pulp cells (DPCs) represent good candidates for the regeneration of dental tissue. This study aimed to evaluate the growth and differentiation potential of DPCs cultured inside demineralized dentin tubules <em>in vivo</em>. Six green fluorescent protein-transgenic rats (body weight 100 g each) and thirty-two Sprague-Dawley (SD) male rats (body weight 250 g each) were used for DPC collection and dentin tubules preparation and transplantation, respectively. Third-passage DPCs with or without collagen gels were loaded into demineralized dentin tubules. Both types of grafts were transplanted into the rectus abdominis muscles of SD rats and were harvested after 21 days. The expression of alkaline phosphatase (ALP), bone sialoprotein (BSP), osteopontin (OPN), nestin, and dentin sialoprotein (DSP) was analyzed by immunohistochemistry. Histological analysis showed that DPCs in the collagen gel formed an osteodentin-like hard tissue matrix after 21 days. Increased positive immunoreactivity for ALP, BSP, OPN, nestin, and DSP was observed in experimental groups compared with control. Our results demonstrate that DPCs in collagen gel inside demineralized dentin tubules show increased growth and differentiation.</p> 2020-11-02T00:00:00+01:00 Copyright (c) 2020 Sultan Zeb Khan, Sana Mirza, Samina Karim, Takashi Inoue, Mohammed S. Bin-Shuwaish, Laila Al Deeb, Khold Al Ahdal, Rana S. Al-Hamdan, Ahmed M. Maawadh, Fahim Vohra, Tariq Abduljabbar http://bjbms.org/ojs/index.php/bjbms/article/view/4471 Inflammation-related cytokines and their roles in gastroenteropancreatic neuroendocrine neoplasms 2020-09-18T13:03:39+02:00 Davorka Herman Mahečić dherman_cro@yahoo.com Maja Cigrovski Berković maja.cigrovskiberkovic@gmail.com Vanja Zjačić-Rotkvić vanja.zjacicrotkvic@kbcsm.hr Tamara Čačev tcacev@irb.hr Sanja Kapitanović kapitan@irb.hr Monika Ulamec monika.ulamec@gmail.com <p>Proinflammatory counterworks are important at different stages of tumor development, particularly during invasion and metastasis. Immune cells and their signal molecules can influence all stages of tumor progression, as well as therapeutic intervention. Proinflammatory cytokines are known triggers of growth in gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs). In this study, we explored the immunohistochemical expression of tumor necrosis factor alpha (TNF-α), interleukin 1 beta (IL-1β), IL-2, and IL-6 in tissues from 43 GEP-NEN patients with tumors of gastric, duodenal, ileal, appendiceal, and colonic origin. The immunohistochemical expression of TNF-α was increased in tumor groups with high proliferation rates (Ki-67; <em>p</em> = 0.034), as well as in those with higher tumor grades (<em>p</em> = 0.05). Moreover, the immunohistochemical expression of TNF-α positively correlated with death outcomes (<em>p</em> = 0.016). Expression of IL-6, IL-1β, and IL-2 displayed similar immunohistochemical expression patterns regardless of Ki-67, although the expression between the ILs differed. Most GEP-NENs had high levels of IL-6 and lower levels of IL-1β and IL-2. Although further comprehensive studies are required for a complete understanding of activated mechanisms in proinflammatory protumoral microenvironment of GEP-NENs, TNF-α is a potential marker in the prognosis of those tumors.</p> 2020-11-02T00:00:00+01:00 Copyright (c) 2020 Davorka Herman Mahečić, Maja Cigrovski Berković, Vanja Zjačić-Rotkvić, Tamara Čačev, Sanja Kapitanović, Monika Ulamec http://bjbms.org/ojs/index.php/bjbms/article/view/4656 Endothelial loss during the surgical procedure in saphenous veins harvested by open and endoscopic techniques in coronary artery bypass surgery 2020-09-18T13:03:39+02:00 Aleksandra Milutinović sandramilutinovic@yahoo.com Ruda Zorc-Pleskovič Ruda.Zorc-Pleskovic@mf.uni-lj.si <p>The patency of the vein graft in coronary artery bypass grafting could be dependent on the conventional open (vsO) or endoscopic (vsE) harvesting and on the hypoxic damage of endothelial cells. We aimed to evaluate both surgical techniques according to endothelial loss that occurs in the time between harvesting and implantation. Twenty-six saphenous veins were divided into vsO (n = 16) and vsE (n = 10) group. Three samples were taken from each vein. The first sample was taken after removal, the second before implantation of the distal part, and the third before the implantation of the proximal part, and they were stained with HE, Movat, and immunohistochemically with CD31. A significant loss of endothelial cells within both groups was found at the time of implantation of the distal and the proximal part of the vein graft compared to the endothelial cells at the time of harvesting. There were no significant differences in the endothelial loss between vsE and vsO groups at the time of harvesting and at the time before the implantation of the distal part. A higher number of endothelial cells was found in vsE group compared to vsO group at the time just before the implantation of the proximal part. The comparison of the implanted portions of vsE and vsO grafts to mammary arteries revealed a significant loss of endothelial cells only in vsO graft. We conclude that, at the time of implantation, the endothelial layer of the vein graft harvested endoscopically is more preserved than of the vein graft harvested openly.</p> 2020-11-02T00:00:00+01:00 Copyright (c) 2020 Aleksandra Milutinović, Ruda Zorc-Pleskovič http://bjbms.org/ojs/index.php/bjbms/article/view/4500 Percutaneous coronary intervention assisted by invasive mechanical ventilation and intra-aortic balloon pump for acute myocardial infarction with cardiogenic shock: Retrospective cohort study and meta-analyses 2020-09-18T13:03:40+02:00 Yin Liu yinliu344@edumedcn.com Chang-Ping Li changpingli47@edumedcn.com Peng-Ju Lu pengjulu879@edumedcn.com Xu-Ying Wang xuyingwang45@edumedcn.com Jian-Yong Xiao jianyongxiao46@edumedcn.com Ming-Dong Gao mingdonggao2@edumedcn.com Ji-Xiang Wang jixiangwang00@edumedcn.com Xiao-Wei Li xiaoweili333@edumedcn.com Nan Zhang nanzhang332@edumedcn.com Chun-Jie Li gaojing2088@163.com Jun Ma junma5776@edumedcn.com Jing Gao jinggaos41s@medsub.cn <p>There is little evidence to recommend the optimal invasive mechanical ventilation (IMV) modes and ideal positive end-expiratory pressure stress levels for acute myocardial infarction-cardiogenic shock (AMI-CS) patients. The aim of this study was to compare the mortality outcome in patients with AMI-CS who were treated with percutaneous coronary intervention (PCI) assisted by intra-aortic balloon pump (IABP) + IMV with historical controls. From January 1, 2016 to June 1, 2017, 60 patients were retrospectively enrolled at Tianjin Chest Hospital. Out of these, 88.3% of patients achieved thrombolysis in myocardial infarction (TIMI) flow 3 after PCI. The all-cause mortality rate in-hospital and at 1 year was 25% (95% CI: 0.14–0.36) and 33.9% (0.22–0.46), respectively. A systematic review followed by meta-analysis was performed with four historical studies of patients treated by PCI + IMV with partial IABP, which found an in-hospital mortality rate of 66.0% (95% CI: 0.62–0.71). Recently, a meta-analysis of patients receiving PCI + IABP with partial IMV showed that the 1 year mortality rate was 52.2% (95% CI: 0.47–0.58). In Cox regression analysis of patient data from the current study, lactic acid level ≥4.5 mmol/L, hyperuricemia, and TIMI flow &lt;3 were independent predictors of death at 1 year. All-cause mortality, in-hospital and at 1 year, in patients with AMI-CS treated with PCI + IABP and IMV was lower than in those treated with PCI + partial IABP or IMV. Larger, longer-term direct comparisons are warranted.</p> 2020-11-02T00:00:00+01:00 Copyright (c) 2019 The author(s) http://bjbms.org/ojs/index.php/bjbms/article/view/4764 Clinical Nocardia species: Identification, clinical characteristics, and antimicrobial susceptibility in Shandong, China 2020-09-18T13:03:41+02:00 Shu-Hua Lu lushuhua010515@126.com Zhen-Wen Qian peipei820928@163.com Pei-Pei Mou peiyang9952@163.com Lian Xie jingchao70@126.com <p><em>Nocardia</em> is a pathogen responsible for a variety of clinical infections. Here, we aimed to investigate the species distribution, clinical manifestations, and antimicrobial susceptibility of <em>Nocardia</em> species over 3 years in two tertiary general hospitals in China. In this retrospective study, a total of 27 <em>Nocardia</em> species were isolated from 27 individuals between January 2017 and December 2019. <em>Nocardia</em> isolates were identified to species level by mass spectrometry and 16S rRNA PCR sequencing. Clinical data were collected from medical records. Antimicrobial susceptibility was determined by the standard Broth microdilution method. The 27 patients with <em>Nocardia</em> infection included 12 males and 15 females with a mean age of 60.11 years. Among 27 <em>Nocardia</em> isolates, 7 species were identified, with the most common species being <em>Nocardia otitidiscaviarum</em> (40.7%). The antimicrobial susceptibility profiles varied between different <em>Nocardia</em> species. Notably, all<em> Nocardia</em> isolates were linezolid susceptible. The majority of <em>Nocardia</em> isolates were collected from a department of respiratory medicine (55.56%) and sputum specimen (44.44%). Pulmonary region was the most involved body site (70.37%) followed by skin (7.4%) and pleural cavity (7.4%). Most patients with <em>Nocardia</em> infection needed combination antibiotic therapy. Two deaths were reported during the treatment period and 24 patients achieved improvement after antibiotic therapy. The clinical manifestations of <em>Nocardia</em> infection and antimicrobial susceptibility profiles varied with diverse <em>Nocardia</em> species. Thus, the accurate identification of these species is crucial for the diagnosis and the selection of antibiotic treatment.</p> 2020-11-02T00:00:00+01:00 Copyright (c) 2020 Shu-Hua Lu, Zhen-Wen Qian, Pei-Pei Mou, Lian Xie http://bjbms.org/ojs/index.php/bjbms/article/view/4748 Chronic maxillary sinusitis of dental origin and oroantral fistula: The results of combined surgical approach in an Italian university hospital 2020-09-18T13:03:41+02:00 Massimo Galli massimo.galli@uniroma1.it Giulia De Soccio giulia.desoccio@uniroma1.it Fabrizio Cialente fabrizio.cialente@uniroma1.it Francesca Candelori francesca.candelori@uniroma1.it Francesca Romana Federici f.federici@uniroma1.it Massimo Ralli massimo.ralli@uniroma1.it Marco de Vincentiis marco.devincentiis@uniroma1.it Antonio Minni antonio.minni@uniroma1.it <p>Unilateral chronic maxillary sinusitis is a possible complication of odontogenic disease or dental treatment and is mainly due to the development of an oroantral fistula (OAF). The management of chronic maxillary sinusitis of dental origin (CMSDO) requires a combined treatment via endoscopic sinus surgery (ESS) and intraoral surgical treatment of the odontogenic source. The aim of this study is to present the results of our university hospital unit in the treatment and follow-up of a case series of 34 patients treated with a combined surgical approach for CMSDO due to OAF. All patients were treated with ESS combined with an intraoral approach. No intraoperative or immediate postoperative complications were observed; nasal synechia was found in 3 patients (8.82%). The overall success rate after the primary intervention was 94.12%; recurrence was observed in 2 cases (5.88%), both were suffering from diabetes mellitus and were tobacco smokers. Our results confirm that simultaneous surgery with a combination of an intraoral and endoscopic approach can be considered the best strategy for the long-term restoration of normal sinonasal homeostasis in selected patients with chronic odontogenic sinusitis and OAF, guaranteeing an effective treatment with minimal complications in the short and long term.</p> 2020-11-02T00:00:00+01:00 Copyright (c) 2020 Massimo Galli, Giulia De Soccio, Fabrizio Cialente, Francesca Candelori, Francesca Romana Federici, Massimo Ralli, Marco de Vincentiis, Antonio Minni http://bjbms.org/ojs/index.php/bjbms/article/view/4503 Overexpression of microRNA-129-5p in glioblastoma inhibits cell proliferation, migration, and colony-forming ability by targeting ZFP36L1 2020-09-18T13:03:39+02:00 Xu Guo gx0510@126.com Haozhe Piao piaohaozhe2019@163.com Ye Zhang zy712@139.com Peixin Sun sunpx777@sina.com Bing Yao 921053009@qq.com <p>Glioblastoma multiforme (GBM) is a highly invasive cancer with a high recurrence rate. The prognosis of GBM patients remains poor, even after standard surgical resection combined with chemoradiotherapy. Thus, there is an urgent need for new therapeutic targets in GBM. In recent years, microRNAs have received considerable attention due to their important role in tumor development and progression. In this study, we investigated the role of miR-129-5p and miR-129-5p/ZFP36L1 axis in GBM tumorigenesis. Analysis of GSE103228 microarray data from the GEO database showed that miR-129-5p was significantly downregulated in GBM vs. normal brain tissues. Quantitative reverse transcription PCR analysis of miR-129-5p expression in seven GBM cell lines (LN229, A172, U87, T98G, U251, H4, and LN118) vs. normal human astrocytes (NHA) showed miR-129-5p was significantly downregulated in GBM cells. Overexpression of miR-129-5p in LN229 and A172 cells significantly suppressed cell proliferation, migration, invasion, and colony-forming ability. Target Scan analysis identified <em>ZFP36L1</em> as the target of miR-129-5p. UALCAN dataset analysis found that <em>ZFP36L1</em> was significantly upregulated in GBM vs. normal brain tissues, and high <em>ZFP36L1</em> expression was positively associated with poor survival of GBM patients. Western blot analysis demonstrated that ZFP36L1 was significantly upregulated in seven GBM cell lines vs. NHA. Overexpression of miR-129-5p in LN229 and A172 cells significantly inhibited ZFP36L1 mRNA and protein expression, while overexpression of ZFP36L1 in LN229 and A172 cells reversed miR-129-5p-mediated inhibition on GBM tumorigenesis. Our results revealed an important role of miR-129-5p in the negative regulation of <em>ZFP36L1</em> expression in GBM, suggesting new candidates for targeted therapy in GBM patients.</p> 2020-11-02T00:00:00+01:00 Copyright (c) 2019 Xu Guo, Haozhe Piao, Ye Zhang, Peixin Sun, Bing Yao http://bjbms.org/ojs/index.php/bjbms/article/view/4636 High MTHFR promoter methylation levels in men confer protection against ischemic stroke 2020-09-18T13:03:39+02:00 Shan Xu 20450971@qq.com Qianping Shi 707232433@qq.com Bo Li 54222538@qq.com Liyuan Han hanqichunchen@126.com Guodong Xu guodonghsu@qq.com Xiaolin Peng 25731738@qq.com Hongen Chen 654017876@qq.com Shuhong Dai 290785782@qq.com Wancheng Ma 303883061@qq.com Changyi Wang wangchangyi2002@163.com Jianping Ma 710321019@qq.com <p>The <em>MTHFR</em> gene encodes methylenetetrahydrofolate reductase required for the metabolism of homocysteine (Hcy) – a previously reported independent risk factor for ischemic stroke (IS). In this study, we first aimed to clarify the association between DNA methylation levels in the <em>MTHFR</em> promoter and the risk of IS, followed by the analysis of potential interactions between environmental factors and DNA methylation levels that affect IS risk. We recruited 164 patients with hypertension and IS (case group) and 345 age-matched and sex-matched patients with hypertension only (control group). Demographic and clinical information was obtained using questionnaires, and blood samples were collected for biochemical analyses. Fluorescence quantitative methylation-specific PCR (qMSP) was used to detect <em>MTHFR</em> promoter methylation levels. A logistic regression analysis was performed to determine the relationship between environmental factors, <em>MTHFR</em> promoter methylation levels, and IS risk. We finally generated a receiver operating characteristic curve to determine whether <em>MTHFR</em> promoter methylation levels can predict IS. The mean <em>MTHFR</em> methylation levels in the case group (8.10 ± 6.14) were significantly lower than those in the control group (17.44 ± 3.16; <em>p &lt;</em> 0.05). <em>MTHFR</em> promoter methylation levels were also lower in patients with plasma Hcy levels ≥15 μmol/L (10.65 ± 4.05) than in those with Hcy levels &lt;15 μmol/L (16.74 ± 4.26, <em>p &lt;</em> 0.001). Finally, we found that <em>MTHFR</em> hypermethylation is a protective factor for IS, particular in men (OR in men: 0.07; 95% CI: 0.02–0.16; <em>p </em>&lt; 0.001). Further, sex and <em>MTHFR</em> promoter methylation levels exhibited a preliminary interaction effect on IS risk. These results indicate that <em>MTHFR</em> promoter methylation status might have diagnostic value in IS.</p> 2020-11-02T00:00:00+01:00 Copyright (c) 2020 Shan Xu, Qianping Shi, Bo Li, Liyuan Han, Guodong Xu, Xiaolin Peng, Hongen Chen, Shuhong Dai, Wancheng Ma, Changyi Wang, Jianping Ma http://bjbms.org/ojs/index.php/bjbms/article/view/4535 DNA methylation of AHCY may increase the risk of ischemic stroke 2020-09-18T13:03:39+02:00 Lei Zhao vejiita@163.com Xiaosheng Chen 469252146@qq.com Shengjun Zhou fhzsj@126.com Zhiqing Lin nbyylzq@aliyun.com Xi Yu yuxizhenhao@163.com Yi Huang huangy102@gmail.com <p>Genetic factors play an important role in the pathogenesis of ischemic stroke. Of these, epigenetic modifications provide a new direction for the study of ischemic stroke pathogenesis. This study aimed to determine the correlation between DNA methylation of the gene encoding S-adenosylhomocysteine hydrolase (<em>AHCY</em>) and the risk of ischemic stroke in 64 ischemic stroke patients and 138 patients with traumatic brain injury (control group). The methylation level of <em>AHCY</em> was analyzed using quantitative methylation-specific polymerase chain reaction. Statistically significant differences in <em>AHCY</em> methylation levels were observed between the case group [medians (interquartile range): 0.13% (0.09%, 0.27%)] and the control group [0.06% (0.00%, 0.17%), <em>p</em> &lt; 0.0001], and these associations remained significant in both male (<em>p</em> = 0.003) and female (<em>p</em> = 0.0005) subjects. A subgroup analysis by age revealed a considerably higher percentage of methylated <em>AHCY</em> in the case group than the control group in all age groups (age &lt; 60 years, <em>p</em> = 0.007; age ≥ 60 years, <em>p</em> &lt; 0.0001). A receiver operating characteristic (ROC) curve analysis revealed a trend toward a role for <em>AHCY</em> methylation as an indicator of risk in all ischemic patients [area under the curve (AUC) = 0.70, <em>p</em> = 0.0001], male patients (AUC = 0.67, <em>p</em> = 0.004), and female patients (AUC = 0.75, <em>p</em> = 0.0002). Our study confirmed a significant association between the <em>AHCY</em> DNA methylation level and the risk of ischemic stroke, suggesting that this gene methylation pattern may be a potential diagnostic marker of ischemic stroke.</p> 2020-11-02T00:00:00+01:00 Copyright (c) 2020 Lei Zhao, Xiaosheng Chen, Shengjun Zhou, Zhiqing Lin, Xi Yu, Yi Huang http://bjbms.org/ojs/index.php/bjbms/article/view/4711 Monomeric C-reactive protein affects cell injury and apoptosis through activation of p38 mitogen-activated protein kinase in human coronary artery endothelial cells 2020-09-18T13:03:40+02:00 Yong Zhang zhangyongahui@163.com Hongxia Cao hongxia.cao@yandex.com <p>C-reactive protein (CRP) is an important predictor of cardiovascular events and plays a role in vascular inflammation and vessel damage. The aim of this study was to investigate the effect of pentameric CRP (pCRP) and monomeric CRP (mCRP) on the production of atherosclerosis-re­lated factors in cultured human coronary artery endothelial cells (HCAECs). HCAECs were treated with pCRP, mCRP, p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580, or transfected with p38 MAPK siRNA. Western blotting was performed to detect the expression of vascular endothelial growth factor (VEGF), cyclooxygenase-2 (COX-2), intercellular adhesion molecule-2 (ICAM-2) and vascular cell adhe­sion molecule-1 (VCAM-1). Proliferation, damage, and apoptosis of HCAECs were examined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, lactate dehydrogenase (LDH), and flow cytometry, respectively. mCRP suppressed VEGF and COX-2 expression and enhanced ICAM-2 and VCAM-1 expression in HCAECs, in both dose-dependent and time-dependent manner. Except at 100 μg/ml concen­tration and 20-hour or 24-hour incubation, pCRP had no apparent effects. mCRP but not pCRP induced HCAEC injury and phosphorylation of p38 MAPK, and the inhibitor SB203580 reversed the effects of mCRP. mCRP promotes injury and apoptosis of HCAECs through a p38 MAPK-dependent mechanism, which provides a new therapy for the injury of HCAECs in atherosclerosis.</p> 2020-11-02T00:00:00+01:00 Copyright (c) 2020 Yong Zhang, Hongxia Cao http://bjbms.org/ojs/index.php/bjbms/article/view/4499 Human brucellosis in pregnancy – an overview 2020-09-18T13:03:38+02:00 Mile Bosilkovski milebos@yahoo.com Jurica Arapović jurica.arapovic@mef.sum.ba Fariba Keramat faribakeramat@yahoo.com <p>Human brucellosis during pregnancy is characterized by significantly less pronounced adverse obstetric outcomes than in animals, but with remarkably more adverse obstetric outcomes when compared to healthy pregnant women. Seroprevalence of brucellosis in pregnancy and cumulative incidence of brucellosis cases per 1000 delivered obstetrical discharges in endemic regions were reported to be 1.5–12.2% and 0.42–3.3, respectively. Depending on the region, the frequency of pregnant women in the cohorts of patients with brucellosis was from 1.5% to 16.9%. The most common and the most dramatic unfavorable outcomes during brucellosis in pregnancy are the obstetric ones, manifested as abortions (2.5–54.5%), intrauterine fetal death (0–20.6%), or preterm deliveries (1.2–28.6%), depending on the stage of pregnancy. Other unfavorable outcomes due to brucellosis are addressed to infant (congenital/neonatal brucellosis, low birth weight, development delay, or even death), the clinical course of disease in mother, and delivery team exposure. When diagnosed in pregnant women, brucellosis should be treated as soon as possible. Early administration of adequate therapy significantly reduces the frequency of adverse outcomes. Rifampicin in combination with trimethoprim-sulfamethoxazole for 6 weeks is the most commonly used and recommended regimen, although monotherapies with each of these two drugs are also widely used while waiting for the results from prospective randomized therapeutic trials. As no effective human vaccine exists, screening of pregnant women and education of all women of childbearing age about brucellosis should be compulsory preventive measures in endemic regions.</p> 2020-11-02T00:00:00+01:00 Copyright (c) 2019 BJBMS http://bjbms.org/ojs/index.php/bjbms/article/view/4664 Can telomere length predict bone health? A review of current evidence 2020-09-18T13:03:38+02:00 Sok Kuan Wong jocylnwsk@gmail.com Soelaiman Ima-Nirwana imasoel@ppukm.ukm.edu.my Kok-Yong Chin chinkokyong@ppukm.ukm.edu.my <p>Telomeres are repetitive DNA sequences located at the end of chromosomes that serve as a protective barrier against chromosomal deterioration during cell division. Approximately 50–200 base pairs of nucleotides are lost per cell division, and new repetitive nucleotides are added by the enzyme telomerase, allowing telomere maintenance. Telomere shortening has been proposed as an indicator for biological aging, but its relationship with age-related osteoporosis is ambiguous. We summarize the current evidence on the relationship between telomere length and bone health in experimental and epidemiological studies, which serve as a scientific reference for the development of novel diagnostic markers of osteoporosis or novel therapeutics targeting telomere and telomerase of bone cells to treat osteoporosis.</p> 2020-11-02T00:00:00+01:00 Copyright (c) 2020 Sok Kuan Wong, Soelaiman Ima-Nirwana, Kok-Yong Chin http://bjbms.org/ojs/index.php/bjbms/article/view/4888 Clinical applications of avian eggshell-derived hydroxyapatite 2020-09-18T13:03:38+02:00 Horia Opris horia.opris@gmail.com Simion Bran dr_brans@yahoo.com Cristian Dinu dinu_christian@yahoo.com Mihaela Baciut mbaciut@yahoo.com Daiana Antoaneta Prodan daia_prodan@yahoo.com Alexandru Mester alexandrumester@yahoo.com Grigore Baciut gbaciut@umfcluj.ro <p>The search for bone reconstruction materials and methods is an ongoing challenge. The aim of this review is to systemically search the available literature concerning the clinical performance of eggshell as a substitute material in guided bone regeneration in oral surgery. Five databases (PubMed, Cochrane, Web of Science, Scopus, and Embase) were searched up to February 2020. Clinical trials that used eggshell as a bone substitute material were included in the review. Animal and <em>in vivo</em> studies were excluded from the review. ROBINS-I was used to evaluate the risk of bias. A total of 840 studies were retrieved, out of which 55 full-text articles were screened. Five studies were finally included: one study showed critical and four serious risk of bias. A total of 74 patients and 88 intervention sites were included in the five studies. Clinical and radiological evaluation showed complete healing during the follow-ups. Statistically significant radiological and clinical evidence of new bone formation was achieved for socket preservation, grafting after third molar extraction, and cystic/apicectomy grafting. One patient with complications was reported. Histological analysis and micro computed tomography confirmed that it promotes bone regeneration. A comparison with synthetic hydroxyapatite showed similar healing characteristics. Within the limitations of the included studies, the eggshell can be safely and efficiently used in guided bone regeneration procedures, but more research is needed to completely evaluate the full potential of this material.</p> 2020-11-02T00:00:00+01:00 Copyright (c) 2020 Horia Opris, Simion Bran, Cristian Dinu, Mihaela Baciut, Daiana Antoaneta Prodan, Alexandru Mester, Grigore Baciut http://bjbms.org/ojs/index.php/bjbms/article/view/4643 Upper limb principal arteries variations: A cadaveric study with terminological implication 2020-09-18T13:03:40+02:00 Marek Konarik marek.equal@gmail.com Vladimir Musil vladimir.musil@lf3.cuni.cz Vaclav Baca Vaclav.Baca@vspj.cz David Kachlik david.kachlik@lfmotol.cuni.cz <p>Although the variability of the upper limb arteries is a clinically important problem, the prevalence is varying across the existing studies and classification is rather complicated, not well established and sometimes even unclear for simple and direct understanding and usage. Multiple case reports appearing in the last years apply incorrect, inappropriate, and sometimes misleading terminology. We performed an anatomical cadaveric study of the variability of the arteries of the upper limb, namely, the axilla, arm, and forearm, in 423 upper limbs embalmed with classical formaldehyde method (Central European population). We proposed to apply the Equality system based on the common trunks for denomination of the axillary artery branches principal variations: <em>Truncus subscapulocircumflexus </em>(22.9%), <em>truncus profundocircumflexus </em>(13.75%)<em>, </em>and<em> truncus bicircumflexus </em>(13.95%). Further, we proposed the terminology system developed by Rodríguez-Niedenführ et al. for the free upper limb principal arterial trunk variations based on the origin, location (in the arm only, or in the arm and forearm), and course (related to the forearm flexor muscles) of the involved artery: <em>Arteria brachialis superficialis </em>(9.5%), <em>arteria brachioradialis superficialis </em>(6.4%), <em>arteria brachioulnaris superficialis</em> (1.9%), <em>arteria brachiomediana superficialis </em>(0.5%), and <em>arteria comitans nervi mediani manus </em>(3.3%). Extensive development of the catheterization methods via the <em>arteria radialis et ulnaris</em> as well as surgical procedures using flaps based on perforating branches of these arteries (including <em>arteria brachioradialis superficialis et brachioulnaris superficialis</em>) necessitate thorough data on prevalence of the variant vessels for safe performance of these procedures to prevent any unexpected situations or to react adequately in such.</p> 2020-11-02T00:00:00+01:00 Copyright (c) 2020 Marek Konarik, Vladimir Musil, Vaclav Baca, David Kachlik http://bjbms.org/ojs/index.php/bjbms/article/view/4761 Association of polymorphisms in TP53 and the promoter region of IL10 with gastric cancer in a Kazakh population 2020-09-18T13:03:41+02:00 Gulmira Kulmambetova kulmambetova@biocenter.kz Ivan Shtefanov ivan_tern@mail.ru Akbota Aitkulova akbotamaratovna3@gmail.com Meruyert Imanbekova meruert.iman@gmail.com Aisha Iskakova aishaisk1@gmail.com Abay Makishev abai.makishev@mail.ru Yerlan Ramankulov ramanculov@biocenter.kz <p>The emerging evidence indicates that single nucleotide polymorphisms (SNPs) of the tumor necrosis factor (<em>TNF</em>), interleukin 10 (<em>IL10</em>), tumor protein p53 (<em>TP53</em>), and cluster of differentiation 14 (<em>CD14</em>) genes may determine individual susceptibility to gastric cancer (GC). We aimed to investigate the associations for polymorphisms of the <em>TNF</em>, <em>IL10</em>, <em>TP53</em>, and <em>CD14</em> genes in a population of Kazakhs, to identify potential risk or protective associations of the SNPs with GC. A case group of 143 patients hospitalized for GC was enrolled. Controls were 355 volunteers with no history of any cancer and frequency matched with cases by age. Differences in proportions for categorical variables and the assessment of genotypic frequencies conforming to the Hardy–Weinberg equilibrium law were evaluated by the Chi-square test. Associations between genetic polymorphisms and the risk of GC were estimated by regression analysis. For genetic analysis, three genetic models (additive, dominant, and recessive) were used. Four significant associations were found. The SNPs rs1042522 of <em>TP53</em> and rs1800896 of <em>IL10</em> were risk factors for GC by the additive model. Two polymorphisms of <em>IL10</em> were protective of GC, namely, rs1800872 by additive model and rs1800871 by recessive model. No significant associations were observed between the <em>TNF</em> and <em>CD14</em> polymorphisms and GC. The polymorphisms <em>TP53</em> rs1042522 and <em>IL10</em> rs1800896 are associated with GC risk, while the polymorphisms <em>IL10</em> rs1800872 and rs1800871 are protective of GC in the population of Kazakhs.</p> 2020-11-02T00:00:00+01:00 Copyright (c) 2020 Gulmira Kulmambetova, Ivan Shtefanov, Akbota Aitkulova, Meruyert Imanbekova, Aisha Iskakova, Abay Makishev, Yerlan Ramankulov http://bjbms.org/ojs/index.php/bjbms/article/view/5016 Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches 2020-09-22T16:47:21+02:00 Dikhnah Alshehri dalshehri@ut.edu.sa Omar Saadah Osaadah@kau.edu.sa Mahmoud Mosli mmosli@kau.edu.sa Sherif Edris seedris@kau.edu.sa Rashad Alhindi rhindi@kau.edu.sa Ahmed Bahieldin abmahmed@kau.sa <p>There is a growing body of evidence reinforcing the unique connections between the host microbiome, health and diseases. Due to the extreme importance of the symbiotic relationship between the intestinal microbiome and the host, it is not surprising that any alteration in the gut microbiota would result in various diseases, including inflammatory bowel disease (IBD), Crohn’s disease (CD) and ulcerative colitis (UC). IBD is a chronic, relapsing-remitting condition that is associated with significant morbidity, mortality, compromised quality of life and costly medical care. Dysbiosis is believed to exacerbate the progression of IBD. One of the currently used treatments for IBD are anti-tumor necrosis factor (TNF) drugs, representing a biologic therapy that is reported to have an impact on the gut microbiota composition. The efficacy of anti-TNF agents is hindered by the possibility of non-response, which occurs in 10-20% of treated patients, and secondary loss of response, which occurs in up to 30% of treated patients. This underscores the need for novel therapies and studies that evaluate the role of the gut microbiota in these conditions. The success of any therapeutic strategy for IBD depends on our understanding of the interactions that occur between the gut microbiota and the host. In this review, the health and disease IBD-associated microbiota patterns will be discussed, in addition to the effect of currently used therapies for IBD on the gut microbiota composition, as well as new therapeutic approaches that can be used to overcome the current treatment constraints.</p> 2020-09-21T23:52:13+02:00 Copyright (c) 2020 Dikhnah Alshehri, Omar Saadah, Mahmoud Mosli, Sherif Edris, Rashad Alhindi, Ahmed Bahieldin http://bjbms.org/ojs/index.php/bjbms/article/view/5026 Postoperative respiratory depression after hysterectomy 2020-09-18T18:09:27+02:00 Mariana L. Laporta laporta.mariana@mayo.edu Michelle O. Kinney kinney.michelle@mayo.edu Darrell R. Schroeder schroedd@mayo.edu Juraj Sprung sprung.juraj@mayo.edu Toby N. Weingarten weingarten.toby@mayo.edu <p>To investigate if sex-specific physiologic characteristics could impact postoperative respiratory depression risks in women, we studied incidence and risk factors associated with postoperative respiratory depression in a gynecologic surgical cohort. Only hysterectomies performed under general anesthesia from 2012 to 2017 were included to minimize interprocedural variability. Respiratory depression was defined as episodes of apnea, hypopnea, hypoxemia, pain-sedation mismatch, unplanned positive airway pressure device application, or naloxone administration in the post-anesthesia care unit. Multivariable logistic regression was used to explore the association with clinical characteristics. From 1,974 hysterectomies, 253 had postoperative respiratory depression, yielding an incidence of 128 (95% confidence interval, 114–144) per 1,000 surgeries. Risk factors associated with respiratory depression were older age (odds ratio 1.22 [95% confidence interval 1.02–1.46] per decade increase, <em>p </em>= 0.03), lower body weight (0.77 [0.62–0.94] per 10 kg/m<sup>2</sup>, <em>p</em> = 0.01), and higher intraoperative opioid dose (1.05 [1.01–1.09] per 10 mg oral morphine equivalents, <em>p</em> = 0.01); while sugammadex use was associated with a reduced risk (0.48 [0.30–0.75], <em>p</em> = 0.002). Respiratory depression was not associated with increased hospital stay, postoperative complications, or mortality. Postoperative respiratory depression risk in women increased with age, lower weight, and higher intraoperative opioids and decreased with sugammadex use; however, it was not associated with postoperative pulmonary complications.</p> 2020-09-15T13:11:55+02:00 Copyright (c) 2020 Mariana L. Laporta, Michelle O. Kinney, Darrell R. Schroeder, Juraj Sprung, Toby N. Weingarten http://bjbms.org/ojs/index.php/bjbms/article/view/4735 An insight into osteoarthritis susceptibility: Integration of immunological and genetic background 2020-09-16T18:09:26+02:00 Debora Stefik deborastefik@gmail.com Vladimir Vranic drvladimirvranic@yahoo.com Nemanja Ivkovic deborastefik@gmail.com Dzihan Abazovic adzihan@gmail.com Dusan Maric ducamaric@gmail.com Danilo Vojvodic vojvodic.danilo@gmail.com Gordana Supic gogasupic@gmail.com <p>Osteoarthritis (OA) is a progressive degenerative disease that affects all synovial joints, causing the disability of the main locomotor diarthrodial joints. OA pathogenesis is caused by a complex interplay between a number of genetic and environmental risk factors, involved in the early onset and progression of this chronic inflammatory joint disease. Uncovering the underlying immunological and genetic mechanisms will enable an insight into OA pathophysiology and lead to novel and integrative approaches in the treatment of OA patients, together with a reduction of the disease risk, or a delay of its onset in susceptible patients.</p> 2020-09-11T14:00:16+02:00 Copyright (c) 2020 Debora Stefik, Vladimir Vranic, Nemanja Ivkovic, Dzihan Abazovic, Dusan Maric, Danilo Vojvodic, Gordana Supic http://bjbms.org/ojs/index.php/bjbms/article/view/4994 LncRNA SENCR suppresses abdominal aortic aneurysm formation by inhibiting smooth muscle cells apoptosis and extracellular matrix degradation 2020-09-17T18:24:46+02:00 Zhou Cai czhou08@hotmail.com Jianhua Huang jhhuang17@qq.com Junxiao Yang yjunxiao@protonmail.com Baihong Pan 2024493948@qq.com Wei Wang wangweii25@foxmail.com Yangyang Ou ouyyang2@protonmail.com Xianwei Wang wxianwei@protonmail.com Pu Yang pyang87@163.com <p>Abdominal aortic aneurysm (AAA) is a progressive chronic dilatation of the abdominal aorta without effective medical treatment. This study aims to clarify the potential of long non-coding RNA SENCR as a treatment target in AAA. Angiotensin II (Ang-II) was used to establish AAA model <em>in vitro</em> and <em>in vivo</em>. Reverse transcription quantitative PCR and western blot were performed to measure the expression of SENCR and proteins, respectively. Annexin V-FITC/PI double staining was carried out to detect the apoptotic rate in vascular smooth muscle cells (VSMCs), and cell apoptosis in aortic tissues was determined by TUNEL staining. Besides, hematoxylin and eosin and Elastica van Gieson staining were performed for histological analysis of aortic tissues. SENCR was downregulated in AAA tissues and Ang-II-stimulated VSMCs. Overexpression of SENCR could inhibit Ang-II-induced VSMC apoptosis, while inhibition of SENCR facilitated Ang-II-induced VSMC apoptosis. Moreover, the expression of matrix metalloproteinase (MMP)-2 and MMP-9 in Ang-II-induced VSMCs was reduced following SENCR overexpression, while tissue inhibitor of metalloproteinases 1 (TIMP-1) expression was increased. <em>In vivo</em>, overexpression of SENCR improved the pathological change in aortic tissues and the damage in arterial wall elastic fibers induced by Ang-II, as well as suppressed Ang-II-induced cell apoptosis and extracellular matrix degradation. Overall, SENCR was decreased in AAA. Overexpression of SENCR inhibited AAA formation via inhibition of VSMC apoptosis and extracellular matrix degradation. We provided a reliable evidence for SENCR acting as a potential target for AAA treatment.</p> 2020-09-08T12:38:11+02:00 Copyright (c) 2020 Zhou Cai, Jianhua Huang, Junxiao Yang, Baihong Pan, Wei Wang, Yangyang Ou, Xianwei Wang, Pu Yang http://bjbms.org/ojs/index.php/bjbms/article/view/4868 The value of lymphocyte count in determining the severity of COVID-19 and estimating the time for nucleic acid test results to turn negative 2020-09-16T16:47:02+02:00 Yuanchao Li 1152111@126.com Tuoyun Yang yangtuoyun@163.com Sicong Wang wangsicong12@sina.com Junbo Zheng icuzhengjunbo@126.com Jing Zhou zhoujingemail@163.com Min Jiang jiangmindoc@163.com Tong Zhou 13604801209@163.com Yang Cao 13604801209@163.com Hongliang Wang icuwanghongliang@163.com <p>Peripheral blood lymphocyte count is shown to be decreased in patients with COVID-19 in the early stage of the disease. The degree of lymphocyte count reduction is related to COVID-19 severity and could be used as an indicator to reflect the disease severity. Our aim was to investigate the value of lymphocyte count in determining COVID-19 severity and estimating the time for SARS-CoV-2 nucleic acid test results to turn negative. We retrospectively analyzed clinical data of 201 patients with severe and critical COVID-19. The patients were admitted to the West Campus of Union Hospital of Tongji Medical College of Huazhong University of Science and Technology. The data included age, gender, chronic disease, lymphocyte count, and SARS-CoV-2 nucleic acid test results. The age of patients in critically ill group was higher than in severely ill group (<em>p</em> = 0.019). The lymphocyte count of critically ill patients was lower than of severely ill patients. The cutoff value of lymphocyte count to distinguish between the critically ill and the severely ill was 0.735 × 10<sup>9</sup>/L (<em>p</em> = 0.001). The cutoff value of lymphocyte count for SARS-CoV-2 nucleic acid test results turning negative in severely and critically ill patients with chronic diseases (hypertension, diabetes, and coronary heart disease) was 0.835 × 10<sup>9</sup>/L (<em>p</em> = 0.017). The cutoff value of lymphocyte count for SARS-CoV-2 nucleic acid test results turning negative in severely and critically ill male patients was 0.835 × 10<sup>9</sup>/L (<em>p</em> &lt; 0.0001). Lymphocyte count could be an effective indicator to predict COVID-19 severity. It may also be useful in determining the time for nucleic acid test results to turn negative in COVID-19 patients with underlying chronic diseases or male COVID-19 patients with severe and critical conditions.</p> 2020-09-07T12:02:24+02:00 Copyright (c) 2020 Yuanchao Li, Tuoyun Yang, Sicong Wang, Junbo Zheng, Jing Zhou, Min Jiang, Tong Zhou, Yang Cao, Hongliang Wang